United therapeutics corporation

Major-Pharmaceuticals

UTHR


1040 Spring Street
Silver Spring , MD 20910

Executive/
Director

Price

  • Last Close
  • $ 356.1
    $ -4.39 -1.22 %
    Jan 3, 2025
  • 52-Week High/Low
  • $359.98 - $210.76
  • YTD
  • 1%

  • Trading Volume
  • 8,339
  • Market Cap Full
  • $ 16.7B
  • Shares Outstanding
  • 47M
    Oct 25, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -28.9% -5.6% -24.1% 7.8% -5% 10.2% -16.9% -20.1% 4.2% 1%
Q2 -4.9% -4.2% 5.3% -34.6% 4% 7.3% 31.2% -1.4% 38.9% -
Q3 11.5% -9.7% 12.4% -3% 8% 2.9% -11.1% 2.3% 15% -
Q4 21.5% 20.7% -13.5% 9.9% 50.3% 17.1% 33.9% -1% -11.3% -
J F M A M J J A S O N D
2025 1% - - - - - - - - - - -
2024 -2.3% 5.1% 1.6% 2.2% 17.5% 15.2% -1.3% 15% - - - -5%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    21%-8%3%-26%-20%74%42%30%-22%60%1%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 4.84 3.89 5.57 -11.32 3.12 0.61 5.03 4.86
Q2 4.52 1.25 3.98 4.66 2.41 3.65 2.41 5.24
Q3 3.63 6.27 2.42 3.01 3.84 3.42 4.91 5.38
Q4 2.64 2.06 1.42 1.26 2.17 2.38 2.65 -
A 15.6 13.5 13.4 -2.4 11.5 10.1 15 15.48

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 43.7 43.9 44.5 45.1 46.3
Jun 43.5 43.8 44 44.8 45.3 46.8
Sep 43.6 43.9 44.4 44.9 45.5 46.9
Dec 43.6 43.9 44.4 45 45.6 47

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.5 1.3 1.2 1.3 2
Fixed Asset Turnover 0.8 0.7 0.7 0.9 1.2
Total Asset Turnover 0.3 0.3 0.3 0.4 0.5
Leverage
Debt Ratio 0.2 0.3 0.4 0.3 0.1
Debt – Equity Ratio 0.2 0.2 0.2 0.2 0.1
Interest Coverage 3.9 7 7.5 2.3 3.7
Equity multiplier 0.5 0.6 0.6 0.6 0.5